Impact of a new levonorgestrel intrauterine system, Levosert^®, on heavy menstrual bleeding: results of a one-year randomised controlled trial

Marie Mawet * Uteron Pharma Sprl, Grace-Hollogne, BelgiumCorrespondence[email protected]

Fabrice Nollevaux Arlenda, Liège, Belgium

Dominique Nizet * Uteron Pharma Sprl, Grace-Hollogne, Belgium

Fabienne Wijzen * Uteron Pharma Sprl, Grace-Hollogne, Belgium

Valérie Gordenne * Uteron Pharma Sprl, Grace-Hollogne, Belgium

Niso TasevDepartment of Gynaecology, General Hospital Kumanovo, Kumanovo, Republic of Macedonia

Dimitrije SegediGynaecology-Obstetrics Clinic, Clinical Centre of Vojvodina, Novi Sad, Serbia

Bogdan Marinescu‘Panait Sarbu’ Obstetrics and Gynaecology Hospital, Bucharest, Romania

Andreea Enache‘Panait Sarbu’ Obstetrics and Gynaecology Hospital, Bucharest, Romania

Vadim Parhomenko ˆComac Medical Ltd, Sofia, Bulgaria

Francis Frankenne * Uteron Pharma Sprl, Grace-Hollogne, Belgium

Jean-Michel Foidart * Uteron Pharma Sprl, Grace-Hollogne, Belgium;University of Liège, Belgium

Your download is now in progress and you may close this window